INS and type 2 diabetes mellitus: These abnormal autoantibodies can damage pancreatic β‐cells through immune‐mediated damage, preventing them from secreting insulin properly.[7, 8] T2D (non‐insulin‐dependent) is characterized mainly by a progressive lack of insulin secretion from pancreatic cells and resistance to insulin action by surrounding target tissues,[7, 9] which accounts for 2%–4% of people and is more common in men.